According to Accelerate Diagnostics's latest financial reports the company has $21.15 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $45.56 M | -28.38% |
2021-12-31 | $63.61 M | -6.81% |
2020-12-31 | $68.26 M | -37.05% |
2019-12-31 | $0.10 B | -34.86% |
2018-12-31 | $0.16 B | 52.51% |
2017-12-31 | $0.10 B | 40.38% |
2016-12-31 | $77.76 M | -41.28% |
2015-12-31 | $0.13 B | 98.6% |
2014-12-31 | $66.67 M | 58.8% |
2013-12-31 | $41.98 M | |
2012-07-31 | $14.26 M | 1738.39% |
2011-07-31 | $0.77 M | 173.89% |
2010-07-31 | $0.28 M | -67.14% |
2009-07-31 | $0.86 M | -30.09% |
2008-07-31 | $1.23 M | -11.52% |
2007-07-31 | $1.39 M | -53.61% |
2006-07-31 | $3 M | -46.01% |
2005-07-31 | $5.56 M | -23.08% |
2004-07-31 | $7.23 M | -16.97% |
2003-07-31 | $8.71 M | 0.94% |
2002-07-31 | $8.63 M | -9.36% |
2001-07-31 | $9.52 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $8.07 B | 38,087.32% | ๐บ๐ธ USA |
Becton Dickinson BDX | $1.18 B | 5,488.39% | ๐บ๐ธ USA |
PerkinElmer
PKI | $2.46 B | 11,536.09% | ๐บ๐ธ USA |
Bruker BRKR | $0.48 B | 2,208.64% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $97.1 M | 359.08% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $1.60 B | 7,498.41% | ๐บ๐ธ USA |